ClinicalTrials.gg
Drug

Enavogliflozin clinical trials

Also written DWP16001.

studies test it
33
open now
14
in phase 3
10
first study started
2017

How each study uses Enavogliflozin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Enavogliflozin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Enavogliflozin
6
DWP16001 0.3mg
5
DWP16001 Drug A
2
DWP16001 Amg
2
Enavogliflozin 0.3mg
2

Development codes

DWP16001
17

Studies by the year they started

33 studies that test it; most in 2023 (6)

Studies that test Enavogliflozin, by start year
YearStudies
20171
20192
20204
20214
20225
20236
20246
20253
20262

By phase

A phase 1/2 study counts in both.

Phase 1
15
Phase 2
1
Phase 3
10
Phase 4
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 25 · Other 8

Daewoong Pharmaceutical Co. LTD. (25) · Yonsei University (3) · Asan Medical Center (1) · Duk-Woo Park, MD (1) · Seoul St. Mary's Hospital (1) · Seoul National University Bundang Hospital (1) · Korea University Anam Hospital (1)

Often tested with

Tested in the same studies.

DWC202511 (1) · DWC202512 (1) · DWJ1525 (1) · DWC202101 (1) · DWC202518 (1) · DWC202407 (1) · DWC202408 (1) · DWC202213 (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 6, 2 in phase 3

Studies that test Enavogliflozin, phase 3 first.

Studies

Open first, then newest update. How each study uses Enavogliflozin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 33

See all 33 studies that test Enavogliflozin →

Codes

What other systems call Enavogliflozin · ClinicalTrials.gg INT002065

  • MeSH (NLM) C000729921EnavogliflozinOne source ClinicalTrials.gov
  • UNII (FDA) Z5MR2Y1IJJENAVOGLIFLOZINConfirmed FDA, Wikidata
  • Wikidata Q123598885enavogliflozinConfirmed FDA, Wikidata
  • NCI Thesaurus C171901EnavogliflozinOne source FDA
  • DrugBank DB18970One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.